Q1 FY27: Consolidated revenue up 35% YoY; PAT rises to 51.22 Cr

Revenue growth above 20%Results View source PDF Explain this filing

ANURAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹1209.80

prior close

₹1223.50

announcement price

In-mkt

timing

Nifty Smallcap 250market-0.5%+0.9% vs market

Specialty Chemicals peers, median of 94sector-0.2%+0.6% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Smallcap 250 and 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.7

15m

-0.4

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4-0.5+0.9-0.2+0.6

Next day

-1.2-0.3-0.9-1.1-0.1

+0.4-0.1+0.5-0.9+1.3

+1.0-0.7+1.8-1.2+2.2

+2.4-0.1+2.6-1.3+3.7

+3.0+0.3+2.7-1.0+4.0

+4.4-0.1+4.5-1.0+5.4

15d

+2.1+0.6+1.5+0.6+1.5

-2.5-2.6+0.1-1.9-0.5

-2.0-2.9+0.9-0.5-1.5

—————

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated revenue from operations grew about 35% YoY to 654.98 Cr in Q1 FY27 (vs 485.83 Cr in Q1 FY26). Consolidated PAT rose to 51.22 Cr from 48.46 Cr. Standalone revenue was 328.81 Cr with PAT of 32.01 Cr (vs 315.69 Cr revenue and 29.69 Cr PAT a year ago). Board also appointed Ravi Desai as Chief Operating Officer.

Likely market impact

Strong consolidated revenue growth signals scale expansion, though standalone PAT growth remained modest at under 10%.